Proficiency of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China, 2008–2021

Author:

Song Yuanyuan,Zhao Bing,Wang Shengfen,Zheng Yang,Zhou Yang,Ou Xichao,Xia Hui,Zhao YanlinORCID

Abstract

To analyze the results of proficiency testing for anti-tuberculosis drug susceptibility testing (DST) in China. Number of laboratory participating the proficiency testing performed DST, and the sensitivity, specificity, reproducibility, and accordance rate were calculated from data of 13 rounds proficiency testing results for DST from 2008 to 2021. A total of 30 and 20 strains of Mycobacterium tuberculosis with known susceptibility results were sent to each laboratory in 2008 to 2019, 2020 and 2021, respectively. The number of participating laboratories ranged from 30 in 2009 to 546 in 2021. L-J DST was the predominant method. The specificity presented relatively higher than sensitivity. Improvement of specificity were observed for all drugs through the years, while sensitivity did not show improvement for amikacin and capreomycin. Accordance rate of pyrazinamide and kanamycin and reproducibility of capreomycin and pyrazinamide were not significantly improved through the years. Most of the participating laboratories significantly improved the quality of their DST through the consecutive rounds of proficiency testing except for second-line injectable drugs and pyrazinamide. The results highlight the importance of developing novel and/or improving existing methods for phenotypic DST for certain drugs.

Funder

Central Government Fund for Tuberculosis Control and Prevention Project

Publisher

Public Library of Science (PLoS)

Reference24 articles.

1. World Health Organization. Global Tuberculosis Report 2022. Geneva: WHO; 2022. https://www.who.int/publications/i/item/9789240061729

2. Members of National and Regional Tuberculosis Reference Laboratories. Proficiency analysis of drug susceptibility testing by national-level tuberculosis reference laboratories from 1995 to 2003;G-H Bai;J Clin Microbiol,2007

3. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories;A Van Deun;Int J Tuberc Lung Dis,2011

4. Evaluation standard of external quality assessment programme for drug susceptibility testing of mycobacterium tuberculosis in Japanese laboratories: proficiency testing in 2004–2010;The Committee for Mycobacterial Examinations;Kekkaku,2015

5. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan, 2007–2011;M-H Wu;Int J Tuberc Lung Dis,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3